999 resultados para 1995_01150505 TM-23 4301102
Resumo:
We report on cooperative downconversion in Yb3+-RE3+ (RE = Tm or Pr) codoped lanthanum borogermanate glasses (LBG), which are capable of splitting a visible photon absorbed by Tm3+ or Pr3+ ions into two near-infrared photons. The results indicate that Pr3+-Yb3+ is a more efficient ion couple than Tm3+-Yb3+ in terms of cooperative downconversion. We have obtained a highest quantum yield of 165% and 138% for Pr3+-Yb3+ and Tm3+-Yb3+ codoped LBG glasses under 468 nm excitation, respectively. However, ultraviolet light excitation to the charge transfer band of Yb3+ does not result in quantum splitting as rapid relaxation from the charge transfer band to 4f(13) levels of Yb3+ dominates. (C) 2008 Optical Society of America
Resumo:
Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências Farmacêuticas
Resumo:
Relatório da Prática de Ensino Supervisionada, Mestrado em Ensino de Economia e Contabilidade, Universidade de Lisboa, 2011
Resumo:
The importance of thrombosis and anticoagulation in clinical practice is rooted firmly in several fundamental constructs that can be applied both broadly and globally. Awareness and the appropriate use of anticoagulant therapy remain the keys to prevention and treatment. However, to assure maximal efficacy and safety, the clinician must, according to the available evidence, choose the right drug, at the right dose, for the right patient, under the right indication, and for the right duration of time. The first International Symposium of Thrombosis and Anticoagulation in Internal Medicine was a scientific program developed by clinicians for clinicians. The primary objective of the meeting was to educate, motivate and inspire internists, cardiologists and hematologists by convening national and international visionaries, thought-leaders and dedicated clinician-scientists in Sao Paulo, Brazil. This article is a focused summary of the symposium proceedings. © Springer Science+Business Media, LLC 2009.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
In a large Phase III trial conducted in 10 Latin American countries, the safety and efficacy of the live attenuated monovalent rotavirus vaccine RIX4414 was evaluated in 15,183 healthy infants followed up during the first two years of life. Belém was the only site in Brazil included in this multicentre trial. The study in Belém included a subset of 653 infants who were followed up until 24 months of age for protection against severe rotavirus gastroenteritis. These subjects were randomly assigned in a 1:1 ratio to receive two doses of vaccine (n = 328) or two doses of placebo (n = 325) at approximately two and four months of age. Of the 653 enrolled infants, 23 dropped out during the study period. For the combined two-year period, the efficacy of RIX4414 was 72.3% [95% confidence interval (CI) 37.5-89.1%] against severe rotavirus-related gastroenteritis, reaching a protection rate of 81.8% (95% CI 36.4-96.6%) against circulating wild-type G9 rotavirus strains. It is concluded that two doses of RIX4414 are highly efficacious against severe rotavirus gastroenteritis in Belém during the first two years of life and provide high protection against the worldwide emergence and spread of G9P[8] strains.
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)